Kathleen Laporte
CIK: 0001196201
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (64 total)
- Jun 12, 2026QTTB
Q32 Bio Inc.
Award(A)DirectStock Option (Right to Buy)
10.8K shares- - Jun 12, 2026QTTB
Q32 Bio Inc.
Award(A)DirectStock Option (Right to Buy)
9.8K shares- - Jun 10, 2026BOLT
Bolt Biotherapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
5K shares- - Jan 15, 2026QTTB
Q32 Bio Inc.
Award(A)DirectStock Option (Right to Buy)
23.3K shares at avg. $2.75- - Jan 15, 2026PRPO
Precipio, Inc.
Award(A)Direct520 shares at avg. $24.00$12K - Jan 7, 2026CERO
CERO THERAPEUTICS HOLDINGS, INC.
Award(A)DirectStock Option (Right to Buy)
690.9K shares- - Jan 2, 2026PRPO
Precipio, Inc.
Award(A)DirectStock Option (Right to Buy)
1.5K shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
Disposition(D)DirectDirector Stock Option (Right to Buy)
1.3K shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
1.3K shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
Disposition(D)DirectDirector Stock Option (Right to Buy)
1.1K shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
Disposition(D)DirectDirector Stock Option (Right to Buy)
1.3K shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
Disposition(D)DirectDirector Stock Option (Right to Buy)
1.1K shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
1.3K shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
Disposition(D)DirectDirector Stock Option (Right to Buy)
1.4K shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
1.3K shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
1.4K shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
Disposition(D)DirectDirector Stock Option (Right to Buy)
1.3K shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
1.3K shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
Disposition(D)DirectDirector Stock Option (Right to Buy)
1.3K shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
1.1K shares- - Dec 12, 2025BOLT
Bolt Biotherapeutics, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
1.1K shares- - Oct 30, 2025ETNB
89bio, Inc.
Disposition(D)DirectStock Option (Right to Buy)
45.2K shares- - Oct 30, 2025ETNB
89bio, Inc.
Disposition(D)DirectStock Option (Right to Buy)
27.4K shares- - Oct 30, 2025ETNB
89bio, Inc.
Disposition(D)DirectStock Option (Right to Buy)
12.5K shares- - Oct 30, 2025ETNB
89bio, Inc.
Disposition(D)DirectStock Option (Right to Buy)
25K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 |  QTTB Q32 Bio Inc. | Award(A) Stock Option (Right to Buy) | 10,826 | - | - | Direct |
| Jun 12, 2026 | QTTB Q32 Bio Inc. | Award(A) Stock Option (Right to Buy) | 9,810 | - | - | Direct |
| Jun 10, 2026 |  BOLT Bolt Biotherapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 5,000 | - | - | Direct |
| Jan 15, 2026 | QTTB Q32 Bio Inc. | Award(A) Stock Option (Right to Buy) | 23,272 | $2.75 | - | Direct |
| Jan 15, 2026 |  PRPO Precipio, Inc. | Award(A) | 520 | $24.00 | $12,480 | Direct |
| Jan 7, 2026 |  CERO CERO THERAPEUTICS HOLDINGS, INC. | Award(A) Stock Option (Right to Buy) | 690,900 | - | - | Direct |
| Jan 2, 2026 | PRPO Precipio, Inc. | Award(A) Stock Option (Right to Buy) | 1,500 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Disposition(D) Director Stock Option (Right to Buy) | 1,250 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Award(A) Director Stock Option (Right to Buy) | 1,250 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Disposition(D) Director Stock Option (Right to Buy) | 1,100 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Disposition(D) Director Stock Option (Right to Buy) | 1,250 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Disposition(D) Director Stock Option (Right to Buy) | 1,100 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Award(A) Director Stock Option (Right to Buy) | 1,250 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Disposition(D) Director Stock Option (Right to Buy) | 1,392 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Award(A) Director Stock Option (Right to Buy) | 1,250 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Award(A) Director Stock Option (Right to Buy) | 1,392 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Disposition(D) Director Stock Option (Right to Buy) | 1,250 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Award(A) Director Stock Option (Right to Buy) | 1,250 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Disposition(D) Director Stock Option (Right to Buy) | 1,250 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Award(A) Director Stock Option (Right to Buy) | 1,100 | - | - | Direct |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | Award(A) Director Stock Option (Right to Buy) | 1,100 | - | - | Direct |
| Oct 30, 2025 |  ETNB 89bio, Inc. | Disposition(D) Stock Option (Right to Buy) | 45,150 | - | - | Direct |
| Oct 30, 2025 | ETNB 89bio, Inc. | Disposition(D) Stock Option (Right to Buy) | 27,400 | - | - | Direct |
| Oct 30, 2025 | ETNB 89bio, Inc. | Disposition(D) Stock Option (Right to Buy) | 12,500 | - | - | Direct |
| Oct 30, 2025 | ETNB 89bio, Inc. | Disposition(D) Stock Option (Right to Buy) | 25,000 | - | - | Direct |
1-25 of 64 transactions
About LAPORTE KATHLEEN
LAPORTE KATHLEEN (SEC CIK 0001196201) files insider reports with the SEC as Director of Q32 Bio Inc. (QTTB), Director of Bolt Biotherapeutics, Inc. (BOLT) and Director of Precipio, Inc. (PRPO). Signal8 also holds filings tied to 2 other companies.
Signal8 holds 23 ownership filings by LAPORTE KATHLEEN, all Form 4s, filed between Sep 6, 2024 and Jul 21, 2026. Those filings report 64 transactions, from Aug 31, 2024 to Jun 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on LAPORTE KATHLEEN's filings is in WALTHAM, MA.
Recent filings by LAPORTE KATHLEEN
- Jun 12, 2026: Grants or awards of QTTB derivative securities (2 lines, Form 4, code A).
- Jun 10, 2026: Grant or award of BOLT derivative securities (Form 4, code A).
- Jan 15, 2026: Grant or award of QTTB derivative securities (Form 4, code A).
- Jan 15, 2026: Grant or award of PRPO shares (Form 4, code A).
- Jan 7, 2026: Grant or award of CERO derivative securities (Form 4, code A).
Other insiders filing for Q32 Bio Inc. (QTTB)
- Morrison Jodie Pope, CEO
- Violette Shelia M., Chief Scientific Officer
- Kalowski Lee, CFO and President
- TZIANABOS ARTHUR, Director
- Lundberg Sven Ante, Director
- Iwicki Mark T, Director